Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil in Pediatric Pulmonary Arterial Hypertension (Double-Blind Phase 3 Study)
jRCT2080222307Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2013
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in pulmonary arterial hypertension (PAH) comparing Tadalafil + ERA with Placebo + ERA (2 arms). Started Nov 2013; status: completed.
02
Drugs
tadalafil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on jRCT2080222307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222307.